Clinical Trials List
Protocol NumberBN120922
2012-10-01 - 2013-12-31
Phase I
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- 席宇廷 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
0 participants
